{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:10:08Z","timestamp":1752153008538,"version":"3.41.2"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,10]]},"DOI":"10.7759\/cureus.87663","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:39:31Z","timestamp":1752151171000},"source":"Crossref","is-referenced-by-count":0,"title":["Pravastatin Mitigates Hypertension, Proteinuria, and Fetal Growth Restriction in an L-NG-Nitro Arginine Methyl Ester (L-NAME)-Induced Rat Model of Preeclampsia"],"prefix":"10.7759","author":[{"given":"Hind A","family":"Elamin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amal M","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magbola M","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"AhmedElharith","family":"ElMahdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181a09fc0","article-title":"Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005","volume":"113","author":"Berg CJ","year":"2009","unstructured":"Berg CJ, MacKay AP, Qin C, Callaghan WM. Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol. 2009, 113:1075-1081. 10.1097\/AOG.0b013e3181a09fc0","journal-title":"Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(00)01223-0","article-title":"Pregnancy-related mortality from preeclampsia and eclampsia","volume":"97","author":"Mackay AP","year":"2001","unstructured":"Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol. 2001, 97:533-538. 10.1016\/S0029-7844(00)01223-0","journal-title":"Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182310c6f","article-title":"Practice bulletin no. 124: inherited thrombophilias in pregnancy","volume":"118","author":"\u00a0American College of Obstetricians and Gynecologists","year":"2011","unstructured":"\u00a0American College of Obstetricians and Gynecologists. Practice bulletin no. 124: inherited thrombophilias in pregnancy. Obstet Gynecol. 2011, 118:730-740. 10.1097\/AOG.0b013e3182310c6f","journal-title":"Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0029-7844(95)00268-V","article-title":"The changing clinical presentation of complete molar pregnancy","volume":"86","author":"Soto-Wright V","year":"1995","unstructured":"Soto-Wright V, Bernstein M, Goldstein DP, Berkowitz RS. The changing clinical presentation of complete molar pregnancy. Obstet Gynecol. 1995, 86:775-779. 10.1016\/0029-7844(95)00268-V","journal-title":"Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1358\/dnp.2009.22.9.1435464","article-title":"From molecules to medicine: a future cure for preeclampsia?","volume":"22","author":"Santillan MK","year":"2009","unstructured":"Santillan MK, Santillan DA, Sigmund CD, Hunter SK. From molecules to medicine: a future cure for preeclampsia?. Drug News Perspect. 2009, 22:531-541. 10.1358\/dnp.2009.22.9.1435464","journal-title":"Drug News Perspect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/0366-6999.225058\/ASSET\/792FACDA-2330-459D-A088-0414FFEB67A3\/ASSETS\/GRAPHIC\/0366-6999-131-04-112-F005.PNG","article-title":"Different effects of pravastatin on preeclampsia-like symptoms in different mouse models","volume":"131","author":"Huai J","year":"2018","unstructured":"Huai J, Yang Z, Yi YH, Wang GJ. Different effects of pravastatin on preeclampsia-like symptoms in different mouse models. Chin Med J (Engl. 2018, 131:461-470. 10.4103\/0366-6999.225058\/ASSET\/792FACDA-2330-459D-A088-0414FFEB67A3\/ASSETS\/GRAPHIC\/0366-6999-131-04-112-F005.PNG","journal-title":"Chin Med J (Engl"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1535370218755690","article-title":"Current model systems for the study of preeclampsia","volume":"243","author":"Martinez-Fierro ML","year":"2018","unstructured":"Martinez-Fierro ML, Hern\u00e1ndez-Delgadillo GP, Flores-Morales V, et al.. Current model systems for the study of preeclampsia. Exp Biol Med (Maywood). 2018, 243:576-585. 10.1177\/1535370218755690","journal-title":"Exp Biol Med (Maywood)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00355.2017","article-title":"Animal models of preeclampsia: translational failings and why","volume":"314","author":"Marshall SA","year":"2018","unstructured":"Marshall SA, Hannan NJ, Jelinic M, Nguyen TP, Girling JE, Parry LJ. Animal models of preeclampsia: translational failings and why. Am J Physiol Regul Integr Comp Physiol. 2018, 314:R499-R508. 10.1152\/ajpregu.00355.2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14598","article-title":"Animal models of preeclampsia: causes, consequences, and interventions","volume":"75","author":"Gatford KL","year":"2020","unstructured":"Gatford KL, Andraweera PH, Roberts CT, Care AS. Animal models of preeclampsia: causes, consequences, and interventions. Hypertension. 2020, 75:1363-1381. 10.1161\/HYPERTENSIONAHA.119.14598","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12460","article-title":"Inventory of novel animal models addressing etiology of preeclampsia in the development of new therapeutic\/intervention opportunities","volume":"75","author":"Erlandsson L","year":"2016","unstructured":"Erlandsson L, N\u00e4\u00e4v \u00c5, Hennessy A, Vaiman D, Gram M, \u00c5kerstr\u00f6m B, Hansson SR. Inventory of novel animal models addressing etiology of preeclampsia in the development of new therapeutic\/intervention opportunities. Am J Reprod Immunol. 2016, 75:402-410. 10.1111\/aji.12460","journal-title":"Am J Reprod Immunol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-017-0774-6","article-title":"Altered endothelial nitric oxide signaling as a paradigm for maternal vascular maladaptation in preeclampsia","volume":"19","author":"Osol G","year":"2017","unstructured":"Osol G, Ko NL, Mandal\u00e0 M. Altered endothelial nitric oxide signaling as a paradigm for maternal vascular maladaptation in preeclampsia. Curr Hypertens Rep. 2017, 19:82. 10.1007\/s11906-017-0774-6","journal-title":"Curr Hypertens Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(94)70179-2","article-title":"Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation","volume":"170","author":"Moln\u00e1r M","year":"1994","unstructured":"Moln\u00e1r M, S\u00fct\u00f6 T, T\u00f3th T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994, 170:1458-1466. 10.1016\/S0002-9378(94)70179-2","journal-title":"Am J Obstet Gynecol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review","volume":"76","author":"Ives CW","year":"2020","unstructured":"Ives CW, Sinkey R, Rajapreyar I, Tita AT, Oparil S. Preeclampsia-pathophysiology and clinical presentations: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 76:1690-1702. 10.1016\/j.jacc.2020.08.014","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13219","article-title":"Statins reverse postpartum cardiovascular dysfunction in a rat model of preeclampsia","volume":"75","author":"Kr\u00e4ker K","year":"2020","unstructured":"Kr\u00e4ker K, O'Driscoll JM, Sch\u00fctte T, et al.. Statins reverse postpartum cardiovascular dysfunction in a rat model of preeclampsia. Hypertension. 2020, 75:202-210. 10.1161\/HYPERTENSIONAHA.119.13219","journal-title":"Hypertension"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2015.12.038","article-title":"Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial","volume":"214","author":"Costantine MM","year":"2016","unstructured":"Costantine MM, Cleary K, Hebert MF, et al.. Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am J Obstet Gynecol. 2016, 214:720.e1-720.e17. 10.1016\/j.ajog.2015.12.038","journal-title":"Am J Obstet Gynecol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high-risk pregnant women","volume":"121","author":"Costantine MM","year":"2013","unstructured":"Costantine MM, Cleary K. Pravastatin for the prevention of preeclampsia in high-risk pregnant women. Obstet Gynecol. 2013, 121:349-353. 10.1097\/AOG.0b013e31827d8ad5","journal-title":"Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2020.03.004","article-title":"Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction","volume":"20","author":"de Alwis N","year":"2020","unstructured":"de Alwis N, Beard S, Mangwiro YT, et al.. Pravastatin as the statin of choice for reducing pre-eclampsia-associated endothelial dysfunction. Pregnancy Hypertens. 2020, 20:83-91. 10.1016\/j.preghy.2020.03.004","journal-title":"Pregnancy Hypertens"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9704607","article-title":"Animal model of gestational diabetes mellitus with pathophysiological resemblance to the human condition induced by multiple factors (nutritional, pharmacological, and stress) in rats","volume":"2016","author":"Abdul Aziz SH","year":"2016","unstructured":"Abdul Aziz SH, John CM, Yusof NIM, Nordin M, Ramasamy R, Adam A, Fauzi FM. Animal model of gestational diabetes mellitus with pathophysiological resemblance to the human condition induced by multiple factors (nutritional, pharmacological, and stress) in rats. Biomed Res Int. 2016, 2016:9704607. 10.1155\/2016\/9704607","journal-title":"Biomed Res Int"},{"key":"ref19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.90.17.8103","article-title":"Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine","volume":"90","author":"Ignarro LJ","year":"1993","unstructured":"Ignarro LJ, Fukuto JM, Griscavage JM, Rogers NE, Byrns RE. Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine. Proc Natl Acad Sci USA\r\n. 1993, 90:8103-8107.","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref20","article-title":"Berberine alleviates preeclampsia possibly by regulating the expression of interleukin-2\/interleukin-10 and Bcl-2\/Bax","volume":"8","author":"Wang A","year":"2015","unstructured":"Wang A, Liu Q, Zhang J, Zheng R. Berberine alleviates preeclampsia possibly by regulating the expression of interleukin-2\/interleukin-10 and Bcl-2\/Bax. Int J Clin Exp Med. 2015, 8:16301-16307.","journal-title":"Int J Clin Exp Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00226\/ASSET\/63501EFF-AD89-4494-A903-A7485D81927F\/ASSETS\/GRAPHIC\/1103FIG07.JPEG","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer AJ","year":"2013","unstructured":"Bauer AJ, Banek CT, Needham K, Gillham H, Capoccia S, Regal JF, Gilbert JS. Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension. Hypertension. 2013, 61:1103-1110. 10.1161\/HYPERTENSIONAHA.111.00226\/ASSET\/63501EFF-AD89-4494-A903-A7485D81927F\/ASSETS\/GRAPHIC\/1103FIG07.JPEG","journal-title":"Hypertension"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa K","year":"2011","unstructured":"Kumasawa K, Ikawa M, Kidoya H, et al.. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A. 2011, 108:1451-1455. 10.1073\/pnas.1011293108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2174\/1389557518666181015151350","article-title":"Radicals, oxidative\/nitrosative stress and preeclampsia","volume":"19","author":"Taysi S","year":"2019","unstructured":"Taysi S, Tascan AS, Ugur MG, Demir M. Radicals, oxidative\/nitrosative stress and preeclampsia. Mini Rev Med Chem. 2019, 19:178-193. 10.2174\/1389557518666181015151350","journal-title":"Mini Rev Med Chem"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2016.01.005","article-title":"The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis","volume":"105","author":"Zhang Z","year":"2016","unstructured":"Zhang Z, Wu P, Zhang J, Wang S, Zhang G. The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: a meta-analysis. Pharmacol Res. 2016, 105:74-83. 10.1016\/j.phrs.2016.01.005","journal-title":"Pharmacol Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00514-2","article-title":"Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions","volume":"33","author":"Kaesemeyer WH","year":"1999","unstructured":"Kaesemeyer WH, Caldwell RB, Huang J, William Caldwell R. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol. 1999, 33:234-241. 10.1016\/S0735-1097(98)00514-2","journal-title":"J Am Coll Cardiol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1080\/14767058.2021.1879785","article-title":"Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study","volume":"35","author":"Akbar MI","year":"2022","unstructured":"Akbar MI, Yosediputra A, Pratama RE, et al.. Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study. J Matern Fetal Neonatal Med. 2022, 35:5375-5382. 10.1080\/14767058.2021.1879785","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202201517","article-title":"The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health","volume":"5","author":"de Alwis N","year":"2022","unstructured":"de Alwis N, Binder NK, Beard S, et al.. The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health. Life Sci Alliance. 2022, 5:10.26508\/lsa.202201517","journal-title":"Life Sci Alliance"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.01.036","article-title":"Pravastatin for severe preeclampsia with growth restriction: placental findings and infant follow-up","volume":"283","author":"Fruci S","year":"2023","unstructured":"Fruci S, Salvi S, Moresi S, et al.. Pravastatin for severe preeclampsia with growth restriction: placental findings and infant follow-up. Eur J Obstet Gynecol Reprod Biol. 2023, 283:37-42. 10.1016\/j.ejogrb.2023.01.036","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385691-pravastatin-mitigates-hypertension-proteinuria-and-fetal-growth-restriction-in-an-l-ng-nitro-arginine-methyl-ester-l-name-induced-rat-model-of-preeclampsia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T12:39:32Z","timestamp":1752151172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385691-pravastatin-mitigates-hypertension-proteinuria-and-fetal-growth-restriction-in-an-l-ng-nitro-arginine-methyl-ester-l-name-induced-rat-model-of-preeclampsia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.87663","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,10]]}}}